CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![ecoa-regulatory-GettyImages-2159342566]( "Improving Transparency And Credibility Of Real-World Evidence: The HARPER Template")
Improving Transparency And Credibility Of Real-World Evidence: The HARPER TemplateHARPER brings consistency to real-world evidence studies, improving transparency and reproducibility while supporting clearer evaluation of methods and findings.
-
![early-onocology-data-GettyImages-2216058350]( "Omics-Driven Immune Challenge Design: What Early Human Data Tells Us")
Omics-Driven Immune Challenge Design: What Early Human Data Tells UsTranscriptomic and proteomic profiling of controlled human immune challenges shows which pathways, compartments, and time windows a model engages, helping match challenge choice to a drug's mechanism.
-
![AI-powered digital document management system, increase efficiency, automate workflow-GettyImages-2253675598]( "Beyond Automation: Transforming Clinical Trial Delivery Through Structured Information")
Beyond Automation: Transforming Clinical Trial Delivery Through Structured InformationStudy build delays stem less from slow tasks than from protocol intent being reinterpreted at every handoff. Treating the protocol as structured, reusable information changes where AI and expertise belong.
-
![IT Programmer working at desk-GettyImages-1354205042]( "Beyond Traditional CTMS And eTMF")
Beyond Traditional CTMS And eTMFTrial data scattered across spreadsheets, emails, and siloed systems slows teams down. Learn how connecting it gives one clear view that catches risks early and keeps studies inspection-ready.
-
![online document verification, file management, data storage-GettyImages-2265259381]( "The PMCF Decision Guide")
The PMCF Decision GuideProposed EU reforms may remove standalone PMCF reporting, yet the duty to proactively collect clinical data remains. Method selection, notified body defense, and data-capture cost determine what comes next.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Stabilizing A Biotech Sponsor's Data Management And Biostatistics Functions8/29/2026
Discover how a rapid mid-study data transition rescued an endangered clinical trial, cleaned up compromised data, and secured a critical interim database lock within twelve months.
-
Driving ROI: A Real-Time Clinical Trial Oversight Solution8/3/2026
Sample errors, delays, and query overload drain clinical trial budgets. Learn how real-time data capture can shorten timelines and protect data quality.
-
Accelerating A Schizophrenia Trial While Ensuring Quality7/31/2026
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
Reserving Data Integrity With Retrospective Manual Entry7/5/2026
A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
CENTRAL LABORATORIES PRODUCTS & SERVICES
Code and approve clinical trial data from any device and keep your safety and efficacy data clean, consistent, and ready for analysis.
ProPharma is committed to ensuring clients achieve optimal results. As your Benchling partner, our team of R&D Technology experts will ensure you obtain the most value from your Benchling software investment.
Avance Clinical has located its Asia hub operations in Seoul, South Korea which is highly regarded for its advanced technology and scientific and medical excellence.
Expert Support for Clinical Research and Research Administration
ProPharma has deep expertise across all signal detection and management activities, including validation, prioritization, and assessment using data from a wide range of sources that are relevant for signal detection for the individual product(s). We are also fully trained and experienced in the EudraVigilance Data Analysis System (EVDAS) functionality and can support MAHs to comply with their obligations for signal detection and management. We leverage our robust knowledge to select the most efficient and effective method(s) for each product that is compliant with legislative requirements.
Zelta’s EDC has been used in more than 4,000 studies from startup to submission, across all phases, including over 500 phase 3c trials and 23 therapeutic areas.
Signals Clinical streamlines clinical data workflows, reducing the time spent preparing data for analytics. Its comprehensive platform enables the rapid delivery of clinical insights that inform both clinical and operational study decisions.
Our industry-leading clinical analytics experts build tools and solutions that efficiently facilitate data management and biometrics activities. By providing advanced services and automating technology, we're able to maximize efficiency, ease interpretation, and deliver actionable insights.
CENTRAL LABORATORIES SOLUTIONS
- Data-Backed Recommendations For Primary Endpoints And I/E Criteria
- Comprehensive Data And Analytics For Cell, Gene, And RNA-Based Therapies
- Trial Transparency Starts Here
- Accelerate Approval Of Novel Therapies
- Synthetic Control Arm®: The Smart External Control Arm Solution
- Elevating Cardiovascular Research With eCOA And Sensors
- Managing Execution Of A Phase III Clinical Trial
- Delivering Precise, Reliable Data For Your Schizophrenia Research
- RWD Solutions
- Simulants: Unlock Insights And Accelerate Medical Breakthroughs
VIDEOS
NEWS
- Suvoda's Latest Release Creates An Experience Across Study Data, Patient Engagement, And Clinical Trial Operations
- ISPOR Launches Its First Interpretive Report On The HARPER Template
- London Biotechnology Show 2026 To Unite Global Life Sciences Leaders, Innovators, Investors
- Suvoda Helps Patients Stay In Trials With More Travel Choice And Control Through Expanded Greenphire Travel
- Suvoda Makes Sofia AI Assistant Available For Clinical Trials To Drive Faster Answers And Action
- Quotient Sciences Proprietary AI-Enhanced Solution Optimizes Formulation In Clinical Study
- Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy
- Ypsomed Opens Production Site In China
- Ypsomed Launches YpsoLoop As The First Autoinjector Platform Designed For Circularity
- Ypsomed Expands Offering For Clinical Studies
- Ypsomed Receives The Red Dot Design Award 2026 For YpsoLoop
- Ypsomed Receives FDA Clearance For SmartPilot
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- Avance Clinical Announces Asia Pacific And Mainland China Expansion Ahead Of BIO International Convention 2026
- The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) Makes Breakthroughs Break Through As Boreal Biomanufacturing
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework